Your browser doesn't support javascript.
loading
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation.
López-Erauskin, Jone; Bravo-Hernandez, Mariana; Presa, Maximiliano; Baughn, Michael W; Melamed, Ze'ev; Beccari, Melinda S; Agra de Almeida Quadros, Ana Rita; Arnold-Garcia, Olatz; Zuberi, Aamir; Ling, Karen; Platoshyn, Oleksandr; Niño-Jara, Elkin; Ndayambaje, I Sandra; McAlonis-Downes, Melissa; Cabrera, Larissa; Artates, Jonathan W; Ryan, Jennifer; Hermann, Anita; Ravits, John; Bennett, C Frank; Jafar-Nejad, Paymaan; Rigo, Frank; Marsala, Martin; Lutz, Cathleen M; Cleveland, Don W; Lagier-Tourenne, Clotilde.
Affiliation
  • López-Erauskin J; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Bravo-Hernandez M; Department of Anesthesiology and Stem Cell Program and Institute for Genomic Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Presa M; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA.
  • Baughn MW; The Jackson Laboratory, Bar Harbor, ME, USA.
  • Melamed Z; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Beccari MS; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Agra de Almeida Quadros AR; Department of Medical Neurobiology, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Arnold-Garcia O; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Zuberi A; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ling K; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Platoshyn O; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Niño-Jara E; Department of Neurosciences, Biodonostia Health Research Institute, San Sebastián, Spain.
  • Ndayambaje IS; CIBERNED, ISCIII (CIBER, Carlos III Institute, Spanish Ministry of Sciences and Innovation), Madrid, Spain.
  • McAlonis-Downes M; The Jackson Laboratory, Bar Harbor, ME, USA.
  • Cabrera L; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA.
  • Artates JW; Department of Anesthesiology and Stem Cell Program and Institute for Genomic Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Ryan J; Department of Anesthesiology and Stem Cell Program and Institute for Genomic Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Hermann A; Department of Neurology, The Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ravits J; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Bennett CF; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Jafar-Nejad P; Ludwig Institute and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Rigo F; The Jackson Laboratory, Bar Harbor, ME, USA.
  • Marsala M; Department of Neurosciences, School of Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Lutz CM; Department of Neurosciences, School of Medicine, University of California at San Diego, La Jolla, CA, USA.
  • Cleveland DW; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA.
  • Lagier-Tourenne C; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA.
Nat Neurosci ; 27(1): 34-47, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37996528
ABSTRACT
The mRNA transcript of the human STMN2 gene, encoding for stathmin-2 protein (also called SCG10), is profoundly impacted by TAR DNA-binding protein 43 (TDP-43) loss of function. The latter is a hallmark of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Using a combination of approaches, including transient antisense oligonucleotide-mediated suppression, sustained shRNA-induced depletion in aging mice, and germline deletion, we show that stathmin-2 has an important role in the establishment and maintenance of neurofilament-dependent axoplasmic organization that is critical for preserving the caliber and conduction velocity of myelinated large-diameter axons. Persistent stathmin-2 loss in adult mice results in pathologies found in ALS, including reduced interneurofilament spacing, axonal caliber collapse that drives tearing within outer myelin layers, diminished conduction velocity, progressive motor and sensory deficits, and muscle denervation. These findings reinforce restoration of stathmin-2 as an attractive therapeutic approach for ALS and other TDP-43-dependent neurodegenerative diseases.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Limits: Animals Language: En Journal: Nat Neurosci Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Limits: Animals Language: En Journal: Nat Neurosci Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos